This review summarises amylin and calcitonin physiology and pathophysiology in obesity and NAFLD and provides insight into the potential therapeutic role of pharmacological doses of amylin and calcitonin of relevance to metabolic diseases including obesity and NAFLD. The gene discussed is CALCA; the disease is obesity due to melanocortin 4 receptor deficiency.